(19)
(11) EP 1 651 210 A1

(12)

(43) Date of publication:
03.05.2006 Bulletin 2006/18

(21) Application number: 04744112.6

(22) Date of filing: 19.07.2004
(51) International Patent Classification (IPC): 
A61K 31/415(1985.01)
A61K 31/545(1985.01)
A61K 9/00(1968.09)
A61P 15/14(2000.01)
A61K 31/167(2000.01)
A61K 31/546(2000.01)
A61P 27/16(2000.01)
(86) International application number:
PCT/IB2004/002461
(87) International publication number:
WO 2005/009436 (03.02.2005 Gazette 2005/05)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 31.07.2003 US 492121 P

(71) Applicant: Pharmacia & Upjohn Company LLC
Kalamazoo, MI 49001 (US)

(72) Inventors:
  • BRITTEN, N. J.; c/o Pfizer Global R. & D.
    Kalamazoo, MI 49001 (US)
  • WALDRON, Niki Ann; c/o Pfizer Global R. & D.
    Kalamazoo, MI 49001 (US)
  • WATTS, Jeffrey Lynn; c/o Pfizer Global R. & D.
    Kalamazoo, MI 49001 (US)
  • HALLBERG, John Walter; c/o Pfizer Global R. & D.
    Kalamazoo, MI 49001 (US)
  • BURNS, John William
    Antigo, WI 54409 (US)

(74) Representative: Rutt, Jason Edward 
Pfizer Limited European Patents Department, Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) DISPERSIBLE FORMULATION OF AN ANTI-INFLAMMATORY AGENT